Jespersen, H., Olofsson Bagge, R., Ullenhag, G., Carneiro, A., Helgadottir, H., Ljuslinder, I., . . . Ny, L. (2019). Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study. BMC Cancer.
Citação norma ChicagoJespersen, Henrik, et al. "Concomitant Use of Pembrolizumab and Entinostat in Adult Patients With Metastatic Uveal Melanoma (PEMDAC Study): Protocol for a Multicenter Phase II Open Label Study." BMC Cancer 2019.
Citação norma MLAJespersen, Henrik, et al. "Concomitant Use of Pembrolizumab and Entinostat in Adult Patients With Metastatic Uveal Melanoma (PEMDAC Study): Protocol for a Multicenter Phase II Open Label Study." BMC Cancer 2019.